timothy sykes logo

Stock News

Tivic Health Shares Increase as Company Files to Sell Over 1 Million Stocks

Tim SykesAvatar
Written by Timothy Sykes Reviewed by Jack Kellogg Fact-checked by Ellis Hobbs
Updated 8/16/2025, 12:37 pm ET 8/16/2025, 12:37 pm ET | 5 min 5 min read
Tivic Health Shares Increase as Company Files to Sell Over 1 Million Stocks Thumbnail

Shares of Tivic Health Systems Inc. plunged 6.57% amid investor skepticism over recent news on future growth strategies.

Healthcare industry expert:

Analyst sentiment – negative

  1. Market Position & Fundamentals: Tivic Health (TIVC) is currently in a challenging market position, primarily indicated by its adverse financial metrics. The company is experiencing unfavorable margins across profitability measures, with an EBIT margin of -1101.6% and a profit margin of -1095.93%. Revenue has been under pressure, declining by 25.95% over the past three years. The absence of profitability ratios such as PE suggests an inability to generate net earnings. Additionally, Tivic’s financial strength ratios—such as a leverage ratio of 1.2 and a current ratio of 1.7—indicate moderate liquidity and negligible debt, but compensated by significant ongoing losses.

  2. Technical Analysis & Trading Strategy: Tivic Health’s recent weekly price patterns reveal considerable volatility. The August 14th session saw prices hit a high of $5.46 before closing at a much lower $3.01, reflecting significant intraday volatility. This price action, combined with a high trading volume observed, suggests bearish sentiment in the absence of robust upward buying support. Furthermore, the closing prices have been progressively lower across the most recent weeks. The dominant trend is downward; thus, a prudent trading strategy would involve anticipating further declines and considering short positions should the $3.5 support level break, while also keeping an eye on resistance around the $3.65 mark.

  3. Catalysts & Outlook: Recent filings for the sale of additional common stock shares by Tivic Health indicate a potential increase in supply, which could further pressure stock prices. Despite these challenges, opportunities arise if the company aligns with industry benchmarks in Healthcare and Medical Equipment & Supplies, emphasizing innovation that could offset its equity dilution. However, without notable advancements, the outlook remains cautious. Resistance is expected near the $4.00 level, with support around $3.00 as crucial. Current sentiment is weighed potentially negative, pending the realization of substantial operational and strategic improvements.

  • Recent share filings reflect a potential shift in liquidity, impacting investor expectations and trading volumes.

  • The increase in stock availability hints at a strategic decision to strengthen the company’s capital resources.

Candlestick Chart

Weekly Update Aug 11 – Aug 15, 2025: On Saturday, August 16, 2025 Tivic Health Systems Inc. stock [NASDAQ: TIVC] is trending down by -6.57%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

Tivic Health Systems Inc. has been navigating through a challenging financial landscape. Key financial metrics from the recent reports highlight a concerning ebit margin of -1101.6% and an equally daunting ebitda margin of -1042.1%. These figures underscore ongoing profitability struggles. The revelation of a loss in net income, recorded at -$1.93M for the quarter ending June 30, 2025, further complicates the financial narrative.

Revenue, amounting to $86,000, indicates a modest scale of operations. However, with a negative return on assets at -131.06%, the value generation appears to be minimal compared to assets employed. The financial reports are not optimistic, portraying a facility needing more robust management intervention to steer clear of further losses.

More Breaking News

In terms of valuation, the lack of a PE ratio due to the company’s pre-tax profit margin of -649.8% reveals significant potential risks. Furthermore, the balance sheet shows a total asset value of $4.51M, overshadowed by substantial liabilities towering at $821,000, highlighting constraints on liquidity. The strategic decision to issue new shares could play a critical part in replenishing funds, albeit with the risk of dilution in existing shareholding.

Conclusion

To sum up, Tivic Health’s strategic decision to increase share availability reflects an urgent need for capital infusion amid financial constraints. While the move may enhance financial liquidity, it introduces new challenges in terms of investor equity and market trust. Market actors and shareholders will keenly observe how this decision affects operational strategies and overall company health. As millionaire penny stock trader and teacher Tim Sykes says, “Preparation plus patience leads to big profits.” The company’s ability to manage funds prudently, alongside its patience in implementing sustainable practices, will be central to affecting a sustainable financial turnaround and its future growth trajectory.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply
Author card Timothy Sykes picture

Tim Sykes

Head Writer at TimothySykes.com, Lead Mentor at the Trading Challenge
In his 20-plus years of trading, Tim has made $7.9 million. In his 15-plus years of teaching, Tim’s Trading Challenge has produced over 30 millionaire students. His philosophy emphasizes small gains and cutting losses quickly.
Read More

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”